An interventional study of VA Compassionate Awareness Learning Module (VA CALM) a mindfulness curriculum. in Spinal Cord Injury and Chronic Pain, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-02.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 76 studies in Spinal Cord Injuries by VA Office of Research and Development — 17 open to participants now, 18 under way, 1 of them phase 3. Spinal Cord Injuries · VA Office of Research and Development.
Among the 76 studies in Spinal Cord Injuries by VA Office of Research and Development, this one is the 51st largest by planned enrollment of the 69 interventional ones that give a count, is one of 2 that started in 2025, is one of 52 with no phase, reaches primary completion later than 7 of the 17 other live ones, and was the 70th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →17 of the 76 studies in Spinal Cord Injuries by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18–60
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
76 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 13 · Phase 3 6 · Phase 4 1
First in 2003; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 20 across the 69 interventional studies, 53 across the 7 observational. Of the 57 that completed or were terminated, 50 (88%) have results posted.
This tab as a report to print or save as PDF → With an account.
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
9 of the studies in Spinal Cord Injuries by VA Office of Research and Development that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05776030VA Office of Research and DevelopmentMulti-speed Ergonomic Wheelchair | 2026-12-31 |
| NCT06130449VA Office of Research and DevelopmentTestosterone and Neural Function in Men With Spinal Cord Injury | 2026-12-31 |
| NCT05157282VA Office of Research and DevelopmentSpinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia | 2027-01-29 |
| NCT05553353VA Office of Research and DevelopmentDosing rTMS for Depression Post-SCI | 2027-04-15 |
| NCT05926596VA Office of Research and DevelopmentLeg Stretching Using an Exoskeleton on Demand for People With Spasticity | 2027-04-30 |
Add all 9 to your calendar (.ics) → With an account.
Among the 76 studies in Spinal Cord Injuries by VA Office of Research and Development, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study involves delivering a mindfulness program that was developed for Veterans called VA Compassionate Awareness Learning Module (VA CALM) to Veterans with spinal cord injuries (SCI) to develop accommodations to make the VA CALM program more accessible for those with SCI. It will involve delivering the unmodified curriculum to a group of Veterans with SCI first to determine what areas need accommodations, working with a group of stakeholders to develop appropriate accommodations, and then delivering 1-2 modified modules via virtual reality to evaluate whether using virtual reality was feasible and acceptable for this program.
The objectives of this study are to explore the feasibility and acceptability of a spinal cord injury (SCI) tailored, evidence-based mindfulness group known as VA Compassionate Awareness Learning Module (VA CALM) when delivered via virtual reality (VR) The project will first assess modification needs for SCI and then explore the feasibility and acceptability of delivering VA CALM-SCI over VR.
The long-term goals and significance of this study include studying the efficacy of VA CALM-SCI for the treatment of chronic pain and examining the comparative effectiveness between VR and video telehealth modalities to build evidence for the modified intervention. This work has the potential to improve care for Veterans with SCI who are at risk of being left out of innovative clinical advancements that improve quality of life and well-being, due to the complexity of their medical condition.
Aim 1: Conduct a formative evaluation of the VA CALM program to develop accommodations to improve program accessibility and acceptability for Veterans with SCI and chronic pain (VA CALM-SCI).
Aim 2: Explore the feasibility and acceptability of delivering VA CALM-SCI over a Virtual Reality platform for Veterans with SCI and chronic pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-Individuals unable to consent for research or medical care are ineligible to participate.
This group will receive the VA CALM mindfulness programming.
Behavioral: VA Compassionate Awareness Learning Module (VA CALM) a mindfulness curriculum.
VA CALM is a 9 week mindfulness curriculum typically delivered at a once/week module pace in group settings during sessions that last approximately 60-90 minutes. Module topics include: Program Introduction, Why mindfulness, Perception, What Makes Something a Pleasant Experience?, Being Stuck, Getting Unstuck, Communication, Mindfulness in Daily Life, and Today is the First Dat of the Rest of Your Life.
Also known as: VA CALM
Mindfulness- Five Facet Mindfulness Questionnaire (FFMQ)
Minimum Score: 1 Maximum Score: 5 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Pain- PROMIS-Pain Numeric Rating Scale (NRS)
Minimum Score: 0 Maximum Score: 10 Score Interpretation: Single item measure, higher scores indicate greater pain intensity.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Mindfulness- Mindfulness Attention Awareness Scale (MAAS)
Minimum Score: 1 Maximum Score: 6 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Pain Interference- PROMIS-Pain Interference (PROMIS-PI, SF8a)
Minimum Score: 8 Maximum Score: 40 Score Interpretation: Scores are converted into a T-score which rescales the score into a standardized score with a mean of 50 and a standard deviation of 10. Higher scores indicate greater pain interference.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Pain Acceptance- Chronic Pain Acceptance Questionnaire-Revised (CPAQ-R)
Minimum Score: 0 Maximum Score: 6 Score Interpretation: Generates scores for two domains: Activity Engagement and Pain Willingness. Scores for each item in a domain are aggregated. Higher scores indicate higher levels of acceptance.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Pain Catastrophizing- Pain Catastrophizing Scale (PCS)
Minimum Score: 0 Maximum Score: 52 Score Interpretation: Generates a total score PCS-T and three subscale scores: Rumination, Magnification, and Helplessness. Total score above 30 indicates clinically relevant level of catastrophizing.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Quality of Life- World Health Organization Quality of Life-Brief (WHOQOL-BREF)
Minimum Score: 4 Maximum Score: 20 Score interpretation: Measure is comprised of 4 quality of life domains: physical health, psychological health, social relationships, and environment. Items for each domain are aggregated, averaged, then scaled for final scoring. Higher scores indicate higher quality of life.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Anxiety- Generalized Anxiety Disorder (GAD-7)
Minimum Score: 0 Maximum Score: 21 Score Interpretation: Higher scores indicate more severe anxiety. 0-4: minimal anxiety, 5-9: mild anxiety, 10-14: moderate anxiety, 15-21: severe anxiety.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Depression- Patient Health Questionnaire-9 (PHQ-9)
Minimum Score: 0 Maximum Score: 27 Score Interpretation: Item scores are aggregated. Higher scores indicate greater depression severity. 0: no depression, 1-4: minimal depression, 5-9: mild depression, 10-14: moderate depression, 15-19: moderately severe depression, 20-27: severe depression.
Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).
Virtual Reality Embodiment- One-Item Presence Scale
Minimum Score: 1 Maximum Score: 10 Score Interpretation: Single item. Higher score indicates greater virtual presence.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Virtual Reality Embodiment- Virtual Embodiment Questionnaire
Minimum Score:1 Maximum Score: 7 Scoring interpretation: Measures 3 domains: Acceptance (ownership), Control (agency), and Change (perceived change in the body scheme). Item scores are aggregated then averaged for each domain. Higher scores indicate greater embodiment.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Acceptability of Virtual Reality- System Usability Scale (SUS)
Minimum Score: 0 Maximum Score: 100 Score interpretation: Items aggregated. Higher scores indicate greater usability.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Acceptability of Virtual Reality- Standardized User Experience Percentile Rank Questionnaire (SUPRQ)
Raw component Minimum Score: 1 Raw component Maximum Score: 5 Percentile Minimum Score: 0 Percentile Minimum Score: 100 Score interpretation: Two scores are generated and evaluated: Raw component score (1-5) which is aggregated and then averaged and percentile score (0-100). Higher scores indicate better user experience for both scales.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Acceptability of Program- Acceptability of Intervention Measure (AIM)
Minimum Score: 1 Maximum Score: 5 Score interpretation: Items aggregated then averaged. Higher scores indicate greater acceptability.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Acceptability of Program- Intervention Appropriateness Measure (IAM)
Minimum Score: 1 Maximum Score: 5 Score interpretation: Items aggregated then averaged. Higher scores indicate greater appropriateness.
Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).
Plan to share: Yes — Individual participant data that underlie the results reported in articles to be published after de-identification (text, tables, figures, and appendices) as required by publishers, funding agencies, and or by law. Further, a Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.
Supporting information: Study protocol
Time frame: Beginning 3 months and ending 36 months following article publication.
Access criteria: Data sharing will be permitted for the purposes of validation of results via replication of analyses with the limited, de-identified database. Individually identifiable information will be removed from any database shared to ensure protection of personal privacy. Further the data will be shared pursuant to a data use agreement which prohibits re-identification.
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Jun 2027, 23 months after the start.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 23 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →